Antidepressant discontinuation syndromes: Clinical relevance, prevention and managementHADDAD, Peter M.Drug safety. 2001, Vol 24, Num 3, pp 183-197, issn 0114-5916Article

Antipsychotic-induced hyperprolactinaemia: Mechanisms, clinical features and managementHADDAD, Peter M; WIECK, Angelika.Drugs (Basel). 2004, Vol 64, Num 20, pp 2291-2314, issn 0012-6667, 24 p.Article

Antidepressant discontinuation manic states: a critical review of the Literature and suggested diagnostic criteriaNARAYAN, Vinesh; HADDAD, Peter M.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 3, pp 306-313, issn 0269-8811, 8 p.Article

Adverse effects of antipsychotics as outcome measuresHAMER, Samantha; HADDAD, Peter M.British journal of psychiatry (Print). 2007, Vol 191, issn 0007-1250, s0, s64-s70 [8 p.], SUP50Article

Bipolar disorderANDERSON, Ian M; HADDAD, Peter M; SCOTT, Jan et al.BMJ (Overseas and retired doctors ed.). 2013, Vol 346, Num 7889, pp 27-32, issn 1759-2151, 6 p.Article

The effect of rate of antidepressant tapering on the incidence of discontinuation symptoms : a randomised studyTINT, Aung; HADDAD, Peter M; ANDERSON, Ian M et al.Journal of psychopharmacology (Oxford). 2008, Vol 22, Num 3, pp 330-332, issn 0269-8811, 3 p.Article

Antipsychotic-related QTc prolongation, torsade de pointes and sudden deathHADDAD, Peter M; ANDERSON, Ian M.Drugs (Basel). 2002, Vol 62, Num 11, pp 1649-1671, issn 0012-6667Article

Misdiagnosis of antidepressant discontinuation symptoms. CommentaryHADDAD, Peter M; QURESHI, Masuda; TYRER, Peter et al.Acta psychiatrica Scandinavica. 2000, Vol 102, Num 6, pp 466-468, issn 0001-690XArticle

Adverse effects of atypical antipsychotics : Differential risk and clinical implicationsHADDAD, Peter M; SHARMA, Sonu G.CNS drugs. 2007, Vol 21, Num 11, pp 911-936, issn 1172-7047, 26 p.Article

Antipsychotics and diabetes: review of non-prospective dataHADDAD, Peter M.British journal of psychiatry. Supplement. 2004, Vol 184, Num 47, pp s80-s86, issn 0960-5371Article

Antidepressant discontinuation (withdrawal) symptoms presenting as 'stroke'HADDAD, Peter M; DEVARAJAN, Sivakumaran; DURSUN, Serdar M et al.Journal of psychopharmacology (Oxford). 2001, Vol 15, Num 2, pp 139-141, issn 0269-8811Article

Incidence of Extrapyramidal Symptoms and Tardive Dvskinesia in Schizophrenia: Thirty-Six-Month Results From the European Schizophrenia Outpatient Health Outcomes StudyNOVICK, Diego; HARO, Josep Maria; BERTSCH, Jordan et al.Journal of clinical psychopharmacology. 2010, Vol 30, Num 5, pp 531-540, issn 0271-0749, 10 p.Article

Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophreniaNOVICK, Diego; HARO, Josep Maria; SUAREZ, David et al.Psychiatry research (Print). 2010, Vol 176, Num 2-3, pp 109-113, issn 0165-1781, 5 p.Article

The place of observational studies in assessing the effectiveness of depot antipsychoticsHADDAD, Peter M; TIIHONEN, Jari; HAUKKA, Jari et al.Schizophrenia research. 2011, Vol 131, Num 1-3, pp 260-261, issn 0920-9964, 2 p.Article

First-generation antipsychotic long-acting injections V.oral antipsychotics in schizophrenia: systematic review of randomised controlled trials and observational studiesHADDAD, Peter M; TAYLOR, Mark; NIAZ, Omair S et al.British journal of psychiatry. Supplement. 2009, Vol 195, Num 52, issn 0960-5371, S20-S28Article

The size, burden and cost of disorders of the brain in the UKFINEBERG, Naomi A; HADDAD, Peter M; SAHAKIAN, Barbara J et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 9, pp 761-770, issn 0269-8811, 10 p.Article

Comparison of treatment discontinuation and hospitalization among nonadherent patients initiating depot or oral typical antipsychotic medicationsNOVICK, Diego; HARO, Josep Maria; BERTSCH, Jordan et al.International clinical psychopharmacology. 2012, Vol 27, Num 5, pp 275-282, issn 0268-1315, 8 p.Article

Antidepressant discontinuation syndrome : Consensus panel recommendations for clinical management and additional researchSCHATZBERG, Alan F; BLIER, Pierre; DELGADO, Pedro L et al.The Journal of clinical psychiatry. 2006, Vol 67, pp 27-31, issn 0160-6689, 5 p., SUP4Article

Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorderPERAHIA, David G; KAJDASZ, Daniel K; DESAIAH, Durisala et al.Journal of affective disorders. 2005, Vol 89, Num 1-3, pp 207-212, issn 0165-0327, 6 p.Article

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reportsHADDAD, Peter M; HELLEWELL, Jonathan S. E; WIECK, Angelika et al.Journal of psychopharmacology (Oxford). 2001, Vol 15, Num 4, pp 293-295, issn 0269-8811Article

Weight change by baseline BMI from three-year observational data: findings from the Worldwide Schizophrenia Outpatient Health Outcomes DatabaseBUSHE, Chris J; SLOOFF, Cees J; HADDAD, Peter M et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 4, pp 358-365, issn 0269-8811, 8 p.Article

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisonsHADDAD, Peter M; DAS, Amlan; KEYHANI, Sarvenaz et al.Journal of psychopharmacology. Supplement to ... 2012, Vol 26, Num 5, pp 15-26, issn 1359-7868, 12 p.Article

A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for SchizophreniaTIIHONEN, Jari; HAUKKA, Jari; TAYLOR, Mark et al.The American journal of psychiatry. 2011, Vol 168, Num 6, pp 603-609, issn 0002-953X, 7 p.Article